Focal segmental glomerulosclerosis as a complication of graft-versus-host disease

Nat Rev Nephrol. 2009 Apr;5(4):236-40. doi: 10.1038/nrneph.2009.11.

Abstract

Background: A 54-year-old man with multiple myeloma underwent peripheral blood stem cell transplantation (PBSCT) with cells donated by his human leukocyte antigen (HLA)-identical sister. Eight months after PBSCT, the patient experienced chronic graft-versus-host disease with skin involvement (generalized erythema), mucosal ulceration, sicca syndrome, and elevated liver enzymes. Two years after PBSCT, the patient developed nephrotic syndrome with massive proteinuria, which required hospitalization.

Investigations: Physical examination, blood and urine analyses, liver function tests, 24 h urinary albumin excretion and renal biopsy.

Diagnosis: Focal segmental glomerulosclerosis as a complication of graft-versus-host disease.

Management: Prednisone, ciclosporin and an angiotensin-converting-enzyme inhibitor.

Publication types

  • Case Reports

MeSH terms

  • Glomerulosclerosis, Focal Segmental / diagnosis*
  • Glomerulosclerosis, Focal Segmental / etiology*
  • Glomerulosclerosis, Focal Segmental / therapy
  • Graft vs Host Disease / diagnosis
  • Graft vs Host Disease / etiology*
  • Graft vs Host Disease / therapy
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / therapy*
  • Peripheral Blood Stem Cell Transplantation / adverse effects*